REPLIGEN CORPORATION - COMMON STOCK
154.70
08-January-25 16:45:00
15 minutes delayed
Stocks
+1.20
+0.78%
Today's range
149.15 - 155.40
ISIN
N/A
Source
NASDAQ
-
Repligen Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference
07 Jan 2025 07:30:00 By Nasdaq GlobeNewswire
-
Repligen Launches the CTech™ SoloVPE® PLUS System
06 Jan 2025 07:30:00 By Nasdaq GlobeNewswire
-
Repligen Announces Publication of the Company’s 2023 Corporate Sustainability Report
12 Dec 2024 07:30:00 By Nasdaq GlobeNewswire
-
Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns
09 Dec 2024 07:30:00 By Nasdaq GlobeNewswire
-
Repligen Reports Third Quarter 2024 Financial Results
12 Nov 2024 07:30:01 By Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Upcoming Investor Conferences
05 Nov 2024 07:30:00 By Nasdaq GlobeNewswire
-
Repligen to Report Third Quarter 2024 Financial Results
31 Oct 2024 07:30:00 By Nasdaq GlobeNewswire
-
Repligen Opens Training & Innovation Center to Elevate Customer Experience
24 Sep 2024 07:30:00 By Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Wells Fargo Healthcare Conference
23 Aug 2024 07:30:00 By Nasdaq GlobeNewswire
-
Repligen Reports Second Quarter 2024 Financial Results
30 Jul 2024 07:30:01 By Nasdaq GlobeNewswire
-
Repligen Announces Agreement to Acquire Chromatography Innovator Tantti
29 Jul 2024 16:00:00 By Nasdaq GlobeNewswire
-
Repligen to Report Second Quarter 2024 Financial Results
16 Jul 2024 07:30:00 By Nasdaq GlobeNewswire
-
Repligen Announces CEO Transition Plan
13 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Upcoming June Investor Conferences
22 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Upcoming May Investor Conferences
07 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
Repligen Reports First Quarter 2024 Financial Results
01 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
Repligen to Report First Quarter 2024 Financial Results
17 Apr 2024 07:30:00 By Nasdaq GlobeNewswire
-
Repligen Appoints Maggie A. Pax to Board of Directors
19 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
21 Feb 2024 07:30:01 By Nasdaq GlobeNewswire
-
NetDania - New 12 months High: REPLIGEN CORPORATION - COMMON STOCK
16 Feb 2024 11:02:45 By NetDania Notify
- <<
- <
- 1
- >